COMPARATIVE-EVALUATION OF CIPROFLOXACIN, ENOXACIN, AND OFLOXACIN IN EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PNEUMONIA

被引：48
|
作者：
KEMMERICH, B
SMALL, GJ
PENNINGTON, JE
机构：
[1] BRIGHAM & WOMENS HOSP, DEPT MED, DIV INFECT DIS, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1986年 / 29卷 / 03期
关键词：
D O I：
10.1128/AAC.29.3.395
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：395 / 399
页数：5
相关论文
共 50 条
  • [21] IN-VITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN, FLEROXACIN, OFLOXACIN AND PIPEMIDIC ACID AGAINST PSEUDOMONAS-AERUGINOSA
    DELATORRE, F
    MARTIN, M
    SUAREZ, A
    MARTIN, E
    SANCHEZ, A
    PICAZO, JJ
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 11 - 12
  • [22] CIPROFLOXACIN IN EXPERIMENTAL AORTIC-VALVE ENDOCARDITIS DUE TO PSEUDOMONAS-AERUGINOSA
    BAYER, AS
    BLOMQUIST, IK
    KIM, KS
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (05) : 641 - 649
  • [23] Pseudomonas aeruginosa in vitro corneal isolate sensitivity to ofloxacin, ciprofloxacin, and trovafloxacin:: A comparative study
    Song, A
    McCulley, TJ
    Lam, BL
    Feuer, WJ
    Miller, D
    Alfonso, EC
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 131 (06) : 795 - 796
  • [24] COMPARATIVE-EVALUATION OF MITOGENICITY AND BASEMENT-MEMBRANE-DEGRADING ACTIVITY OF PSEUDOMONAS-AERUGINOSA SLIME GLYCOLIPOPROTEIN AND ALGINATE
    ANASTASSIOU, ED
    KARAKIULAKIS, G
    MISSIRLIS, E
    MARAGOUDAKIS, ME
    DIMITRACOPOULOS, G
    JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (03) : 490 - 494
  • [25] A PLEIOTROPIC, POSTTHERAPY, ENOXACIN-RESISTANT MUTANT OF PSEUDOMONAS-AERUGINOSA
    PIDDOCK, LJV
    HALL, MC
    BELLIDO, F
    BAINS, M
    HANCOCK, REW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) : 1057 - 1061
  • [26] COMPARATIVE EFFICACIES OF PIPERACILLIN, AZLOCILLIN, TICARCILLIN, AZTREONAM, AND TOBRAMYCIN AGAINST EXPERIMENTAL PSEUDOMONAS-AERUGINOSA PNEUMONIA
    SCHIFF, JB
    PENNINGTON, JE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) : 49 - 52
  • [27] INVESTIGATION OF CIPROFLOXACIN PENETRATION INTO PSEUDOMONAS-AERUGINOSA BIOFILMS
    SUCI, PA
    MITTELMAN, MW
    YU, FP
    GEESEY, GG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) : 2125 - 2133
  • [28] FACTORS INFLUENCING THE ACCUMULATION OF CIPROFLOXACIN IN PSEUDOMONAS-AERUGINOSA
    CELESK, RA
    ROBILLARD, NJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (11) : 1921 - 1926
  • [29] USE OF CIPROFLOXACIN IN THE TREATMENT OF PSEUDOMONAS-AERUGINOSA INFECTIONS
    FOLLATH, F
    BINDSCHEDLER, M
    WENK, M
    FREI, R
    STALDER, H
    REBER, H
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) : 236 - 240
  • [30] ORAL CIPROFLOXACIN TREATMENT OF PSEUDOMONAS-AERUGINOSA OSTEOMYELITIS
    DAN, M
    SIEGMANIGRA, Y
    PITLIK, S
    RAZ, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) : 849 - 852
12345